Oral and Maxillofacial Surgery

Pterygoid implants for the immediate rehabilitation of the atrophic maxilla: A case report of a full arch on 4 implants

Mar 21, 2021 by in Oral and Maxillofacial Surgery Comments Off on Pterygoid implants for the immediate rehabilitation of the atrophic maxilla: A case report of a full arch on 4 implants

Abstract Pterygoid implants are a valid and valuable resource for the rehabilitation of the posterior atrophic maxilla and have been detailed before in the literature. Nonetheless, the full arch rehabilitation…

read more

Inferior Alveolar Nerve Dysfunction following Embolization of Inferior Alveolar Artery Pseudoaneurysm

Mar 21, 2021 by in Oral and Maxillofacial Surgery Comments Off on Inferior Alveolar Nerve Dysfunction following Embolization of Inferior Alveolar Artery Pseudoaneurysm

Abstract We report a case of left inferior alveolar nerve dysfunction following management of left inferior alveolar artery pseudoaneurysm in a 32-year old female following third molar extractions. After failing…

read more

Interesting findings of “Novel Aberrant Mandibular Angle Foramen: A novel Aberrancy mimicking mandibular angle fracture”

Mar 21, 2021 by in Oral and Maxillofacial Surgery Comments Off on Interesting findings of “Novel Aberrant Mandibular Angle Foramen: A novel Aberrancy mimicking mandibular angle fracture”

Abstract Variations in Inferior Alveolar Nerve branching are reported ranging from bi to trifurcation and from unilateral to bilateral in the mandible. The extra branch or branches of the Inferior…

read more

Gingival manifestation of a therapy-related acute myelomonocytic leukemia in a patient with previously treated with R–CHOP scheme for diffuse large B-cell lymphoma

Mar 21, 2021 by in Oral and Maxillofacial Surgery Comments Off on Gingival manifestation of a therapy-related acute myelomonocytic leukemia in a patient with previously treated with R–CHOP scheme for diffuse large B-cell lymphoma

Abstract Standard chemotherapy treatment for Diffuse large B-cell lymphoma (DLBCL), including cyclophosphamide, doxorubicin, vincristine and prednisone, in association with rituximab (CHOP-R) are considered associated to the development of secondary tumors….

read more
Get VIDEdental app for watching clinical videos